Farms.com Home   News

Lower Canola Prices in 2012?

Lower Canola Prices in 2012?


Farmers have received very good prices for the oilseed during the past couple of years, but one analyst says growers may have to reign in their expectations in 2012.

"These markets are cyclical," says Mike Jubinville, an analyst with Pro Farmer Canada. "Not to say that I think we are going into a collapse. I don't believe that. But I think the highs may be in the process of being experienced and we may fade back a bit." 

Jubinville says there will still be opportunities to lock in a profit, but margins may be a little tighter next year.

"In the bad times, it always seem like it's never going to end. In the good times, we think it's going to go on forever, but it doesn't work that way in agriculture," says Jubinville. "We've gone through a two year bullish cycle in ag commodities. We may be starting to see a process where we take a bit of a break."

The biggest concern is market volatily caused by international events, such as the staggering Greek economy and the European currency crisis.

Jubinville made the comments following a presentation at the Canola Expo in Yorkton on Wednesday.  

Source: Saskatoonhomepage.ca


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.